Joseph S. Zakrzewski - Dec 7, 2022 Form 4/A - Amendment Insider Report for Cyteir Therapeutics, Inc. (CYT)

Role: Director
Signature: /s/ Adam M. Veness, as attorney-in-fact for Joseph Zakrzewski
Stock symbol: CYT
Transactions as of: Dec 7, 2022
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 12/8/2022, 08:17 PM
Date Of Original Report: Dec 8, 2022
Previous filing: May 16, 2022
Next filing: Feb 7, 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CYT	Common Stock						213K	Dec 7, 2022	Direct	F1, F2
holding	CYT	Common Stock						149K	Dec 7, 2022	See Footnote	F2, F3

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The original Form 4 filed on December 8, 2022 reported securities in column 5 of Table I as indirectly beneficially owned by the Reporting Person through Z Investments, LLC, but these securities were previously transferred to the Reporting Person and should have been reported as directly beneficially owned by the Reporting Person.
F2	27,551 of the shares of common stock held directly and indirectly by the Reporting Person were acquired upon early exercise of an option and are subject to forfeiture until they vest.
F3	Shares held by Z3 Trust, of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein.

Remarks:

As noted in Footnote 1, this Form 4/A amends the Form 4 filed on December 8, 2022 for this Reporting Person.